Sensei Biotherapeutics, Inc.

NASDAQ
SNSE
paper.types.company
Altı ay boyunca karlılık: -38.6%
Temettü getirisi: 0%
Sektör: Healthcare

0.3 $

0 $ 0%
0.2887 $
0.78 $

paper.min_max_per_year

Promosyon programı Sensei Biotherapeutics, Inc.

Gelişmiş program Basit grafik
Financial Markets by TradingView
Karşılaştırma listesine ekle
İzleme listesine ekle
Portföye ekle
Fiyat bildirimi ekle

Temel parametreler

IPO date
2021-02-04
ISIN
US81728A1088
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт
bağlantı
Tüm parametreler

Seviye

Hafife alma
İsim Anlam Seviye
P/S 0 0
P/BV 0.3207 10
P/E 0 0
Yeterlik
İsim Anlam Seviye
ROA -50.37 0
ROE -58.4 0
ROIC 0 0
Temettüler
İsim Anlam Seviye
Temettü getirisi 0 0
DSI 0 0
Ortalama temettü büyümesi 0 0
Görev
İsim Anlam Seviye
Debt/EBITDA -0.1179 10
Debt/Ratio 0.0848 10
Debt/Equity 0.1817 10
Büyüme dürtüsü
İsim Anlam Seviye
Hasılat, % 0 0
Ebitda, % 81.19 9
EPS, % 72.04 8
Daha fazla ayrıntı

paper.price.prices

Fiyat Common.min. Common.max. Değiştirmek paper.changes_in_industry paper.changes_in_index
common.calendar.number_days.1 0.3 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.7d 0.3269 $ 0 $ 0 $ -8.23 % 0 % 0 %
common.calendar.number_days.30d 0.2955 $ 0 $ 0 $ +1.52 % 0 % 0 %
common.calendar.number_days.90d 0.3697 $ 0.295 $ 0.4242 $ -18.85 % 0 % 0 %
common.calendar.number_days.180d 0.4886 $ 0.2887 $ 0.5083 $ -38.6 % 0 % 0 %
common.calendar.number_days.1y 0.6018 $ 0.2887 $ 0.78 $ -50.15 % 0 % 0 %
common.calendar.number_days.3y 1.91 $ 0.2887 $ 2.22 $ -84.29 % 0 % 0 %
common.calendar.number_days.5y 0.2887 $ 0.2887 $ 22.75 $ +103.91 % 0 % 0 %
common.calendar.number_days.10y 0.2887 $ 0.2887 $ 22.75 $ +103.91 % 0 % 0 %
common.calendar.number_days.ytd 0.53 $ 0.2887 $ 0.5462 $ -43.4 % 0 % 0 %

Ana sahipler

Benzer şirketler

P/E & P/BVEV/Ebitda & Debt/Ebitda


Şirket yönetimi

Süpervizör İş unvanı Ödeme Doğum yılı
Mr. John K. Celebi M.B.A. President, CEO & Director 882.28k 1972 (53 yıl)
Dr. Edward Van der Horst Ph.D. Chief Scientific Officer 630.81k 1974 (51 yıl)
Ms. Lora Pike Vice President of Investor Relations & Communications N/A
Mr. Christopher W. Gerry J.D. Senior VP, General Counsel & Secretary N/A
Ms. Stephanie Krebs M.B.A., M.S. Chief Business Officer N/A 1978 (47 yıllar)
Dr. Aaron Weitzman FACP, M.D., Ph.D. Chief Medical Officer N/A
Mr. Josiah Craver Senior VP of Finance, Principal Financial Officer & Principal Accounting Officer

Şirket bilgileri

Adres: United States, Rockville. MD, 1405 Research Boulevard - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.senseibio.com

Şirket hakkında Sensei Biotherapeutics, Inc.

Sensei Biotherapeutics, Inc., an immuno-oncology company, engages in the discovery and development of therapeutics for cancer patients. Its Tumor Microenvironment Activated Biologics platform is designed to unleash the anti-tumor potential of T cells, as well as human monoclonal antibodies that are selectively active in the tumor microenvironment and target immune checkpoints or other critical immune pathways. The company's pipeline includes SNS-101, SNS-103, and SNS-102, monoclonal antibodies, which are in early development stages for the treatment of solid tumors. It has a collaboration with The University of Washington to conduct preclinical studies for its SNS-101 program. The company was formerly known as Panacea Pharmaceuticals, Inc. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland.